Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1761 (LINC01761) is a human long non-coding RNA (lncRNA) gene located on chromosome 1 (1q21.3, coordinates: 95,474,737-95,479,356, forward strand)[5][1][8]. It is transcribed but does not encode a protein and is annotated as a member of the lncRNA gene class, specifically a long intergenic non-coding RNA—an RNA longer than 200 nucleotides that lies between protein-coding genes and does not overlap any coding regions[5][1][8]. LINC01761 is listed in curated genomics databases such as Ensembl, HGNC (Accession HGNC:52551), BioGPS, and GeneCards, but its biological function, mechanism of action, patterns of expression, and connections to human disease remain poorly characterized and are currently unknown in the biomedical literature[1][5][8]. No credible evidence currently supports its status as a therapeutic target and no drugs are known to interact with this lncRNA. Genome-wide association studies (GWAS) have mapped some intergenic variants to this locus, potentially implicating it as a candidate gene in genetic association studies, but no direct clinical or mechanistic role has been established to date[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1761 (LINC01761).